SrivandanaAkshintalaMDM.B.B.S

Pediatric Hematology & Oncology • Washington, DC

Clinical Fellow at Children's National Medical Center

Join to view full profile

Dr. Akshintala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Akshintala's full profile

Already have an account?

Office
111 Michigan Ave Nw
Dept Of Hematology/Oncology
Washington, DC 20010
Phone+1 202-476-2800

Fax+1 202-476-5685
Is this information wrong?

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2010 - 2013
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2007 - 2010
Maulana Azad Medical CollegeClass of 2004

Certifications & Licensure

NY State Medical License 2015 - 2024
DC State Medical License 2010 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2) Start of enrollment: 2018 Sep 24
Completed
Not Applicable

Publications & Presentations

PubMed

11 citations
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
Srivandana Akshintala, Leigh Marcus, Katherine E. Warren, Robert F. Murphy, Tristan M. Sissung
Pediatric Blood & Cancer. 2015-04-01
49 citations
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1
Andrea M. Gross, Gurbani Singh, Srivandana Akshintala, Andrea Baldwin, Eva Dombi
Neuro-Oncology. 2018-11-12
24 citations
Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imaging.
Rosa Nguyen, Eva Dombi, Srivandana Akshintala, Andrea Baldwin, Brigitte C. Widemann
Journal of Neuro-Oncology. 2015-01-01

Lectures

Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials.
2019 ASCO Annual Meeting - 6/1/2019

Other Languages

Hindi, Telugu, Urdu